Yep, and the price action in the last two weeks of 2021 is very similar to that of the same period in 2020.
It will be interesting to note if the SP in the next 3 months follows a similar pattern to that of the first 3 months in 2020.
It's currently trending that way.
As mentioned previously, I also believe we will only get a serious sustained rerate once we have FDA approval, and I'm expecting that sometime in Q3.
I hope I'm wrong and it's a lot sooner !!
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year, page-30
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
69.0¢ |
Change
-0.025(3.50%) |
Mkt cap ! $156.5M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 69.0¢ | 68.5¢ | $13.72K | 20.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8524 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.5¢ | 3598 | 2 |
View Market Depth
| Last trade - 15.44pm 15/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |